Central
Bringing Excellence in Open Access
JSM Biotechnology & Biomedical Engineering
Cite this article: Atasoy A, Kose GT (2016) Biology of Cancellous Bone Graft Materials and their Usage for Bone Regeneration. JSM Biotechnol Bioeng 3(2):
1051.
*Corresponding author
Ayse g ul Ata so y, Ye d ite p e Unive rsity, Fa c ulty o f
Eng ine e ring a nd Arc hite c ture , De p a rtme nt o f G e ne tic s
a nd Bio e ng ine e ring , 34755, Ista nb ul, Turke y, Te l:
902165780216; E-mail:
Submitte d: 27 April 2016
Accepted: 14 June 2016
Publishe d: 17 June 2016
ISSN: 2333-7117
Copyright
© 2016 Ata so y e t a l.
OPEN ACCESS
Ke ywo rds
• C a nc e llo us b o ne g ra ft
• O rtho p e d ic re se a rc h
• O ste o ind uc tio n
• G ra ft b io lo g y
Review Article
Biology of Cancellous Bone
Graft Materials and their Usage
for Bone Regeneration
Aysegul Atasoy* and Gamze Torun Kose
Department of Genetics and Bioengineering, Yeditepe University, Turkey
Abstract
Bone grafting have been used to treat nonunion, union and acute fractures.
Autologous cancellous bone grafts are still the most effective graft material for
stimulating bone repair since they present osteoconduction, osteoinduction and
osteogenic capacity that are mainly requirements for bone regeneration. However,
there are several negative aspects of autologous cancellous grafts such as additional
surgical site, post-operative complications and inadequate amount of grafts.
Allogeneic cancellous bone grafts, on the other hand, have the same characteristics
as cancellous autograft with the exclusion of osteogenic capacity. Understanding of
various biological processes such as host mediated immune response, osteo-integration
of the graft within host and new bone re-modelling leads to improve the new biological
strategies for endosseous grafts. We’ll discuss the biology of the cancellous bone graft
which is essential to understand host-graft incorporate and also evaluate the specifc
factors associated with the osseous healing around the graft.
ABBREVIATIONS
MSCs: Mesenchymal Stem Cells; DBM: Demineralized Bone
Matrix; PRP: Platelet Rich Plasma; HA: Hydroxyapatite; TCP:
Tricalcium Phosphate; IP-CHA: Interconnected Porous Calcium
Hydroxyapatite ceramics; PLA-PEG: Polymer poly D,L,-lactic acid-
polyethyleneglycol block co-polymer; BMPs: Bone Morphogenetic
Proteins; rhBMPs: Recombinant Bone Morphogenetic Proteins;
PDGFs: Platelets include Platelet Derived Growth Factors; TGF-β:
Transforming Growth Factor-beta; VEGF: Vascular Endothelial
Growth Factor; EGF: Epidermal Growth Factor; IGFs: Insulin-like
Growth Factors; b-FGF: Basic Fibroblast Growth Factor; AATB:
American Association of Tissue Banks; FDA: The U.S. Food and
Drug Administration.
INTRODUCTION
Bone tissue can regenerate and repair itself. However,
in some cases such as massive bone defects or pathological
fractures, bone tissue can’t heal itself resulting in delayed unions
or non-union, bone lesions and fractures with bone loss. Bone
grafting is usually necessary when there is a great loss of healthy
bone substance. After a grave injury, a tumor operation, or when
an artificial joint is replaced, these grafts contribute towards the
rapid anatomical and physiological restoration of tissue defects
in patients. Appropriate bone graft material is generally selected
taking into account several factors such as defect size, graft
shape and their biological and mechanical features, preservation
techniques and graft handling. Bone grafts are widely used
in orthopedic field such as oral maxillofacial, reconstructive
surgery, musculoskeletal injuries and sports medicine involving
bone from minor defects to major bone loss [1].
BONE GRAFT PROPERTIES
Bone grafts show biological and mechanical features and
provide a scaffolding so that new bone can be formed through
osteogenesis, osteoinduction, and osteoconduction [2,3]. Graft
materials should have at least two of these biological properties.
Osteoconduction is described as one of the feature of bone graft
that provides three dimensional scaffold for osteoblasts, facilitate
vascularization and provide the migration of new host cells with
osteogenic activity. Incorporation of bone graft materials depends
on host surrounding viable tissue. Mechanical and biological
properties of host-graft interface should permit the integration
of the graft with the local host bone for successful osteogenic
activity. As a new bone is formed, the graft could be partially or
entirely resorbed through the bone formation process [4-6].
Osteoinduction is defined as the improvement of new bone
formation in which MSCs are gathered from the host tissue
and differentiated into bone cells by the stimulation of new
bone productions such as bone proteins, growth factors and
cytokines. Osteogenesis is the process of new bone formation
results from the transplantation of osteoprogenitor cells along
with the growth factors from the bone graft or the host bed. Only
autograft materials have osteoblast cells and their precursors. In